142 related articles for article (PubMed ID: 24307330)
1. Multi-state models for colon cancer recurrence and death with a cured fraction.
Conlon AS; Taylor JM; Sargent DJ
Stat Med; 2014 May; 33(10):1750-66. PubMed ID: 24307330
[TBL] [Abstract][Full Text] [Related]
2. Improving efficiency in clinical trials using auxiliary information: Application of a multi-state cure model.
Conlon AS; Taylor JM; Sargent DJ
Biometrics; 2015 Jun; 71(2):460-8. PubMed ID: 25585942
[TBL] [Abstract][Full Text] [Related]
3. Joint modelling of colorectal cancer recurrence and death after resection using multi-state model with cured fraction.
Alafchi B; Roshanaei G; Tapak L; Abbasi M; Mahjub H
Sci Rep; 2021 Jan; 11(1):1016. PubMed ID: 33441746
[TBL] [Abstract][Full Text] [Related]
4. Transition probability estimates for non-Markov multi-state models.
Titman AC
Biometrics; 2015 Dec; 71(4):1034-41. PubMed ID: 26148652
[TBL] [Abstract][Full Text] [Related]
5. Assessing Markov and time homogeneity assumptions in multi-state models: application in patients with gastric cancer undergoing surgery in the Iran cancer institute.
Ali Z; Mahmood M; Kazem M; Hojjat Z; Mostafa H; Kourosh HN
Asian Pac J Cancer Prev; 2014; 15(1):441-7. PubMed ID: 24528071
[TBL] [Abstract][Full Text] [Related]
6. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic checks in mixture cure models with interval-censoring.
Scolas S; Legrand C; Oulhaj A; El Ghouch A
Stat Methods Med Res; 2018 Jul; 27(7):2114-2131. PubMed ID: 27815495
[TBL] [Abstract][Full Text] [Related]
8. The cure for colon cancer: results from the EUROCARE study.
Verdecchia A; De Angelis R; Capocaccia R; Sant M; Micheli A; Gatta G; Berrino F
Int J Cancer; 1998 Jul; 77(3):322-9. PubMed ID: 9663589
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian model for estimating multi-state disease progression.
Shen S; Han SX; Petousis P; Weiss RE; Meng F; Bui AA; Hsu W
Comput Biol Med; 2017 Feb; 81():111-120. PubMed ID: 28038345
[TBL] [Abstract][Full Text] [Related]
10. Bayesian analysis for generalized linear models with nonignorably missing covariates.
Huang L; Chen MH; Ibrahim JG
Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment.
Steele SR; Bilchik A; Johnson EK; Nissan A; Peoples GE; Eberhardt JS; Kalina P; Petersen B; Brücher B; Protic M; Avital I; Stojadinovic A
Am Surg; 2014 May; 80(5):441-53. PubMed ID: 24887722
[TBL] [Abstract][Full Text] [Related]
12. Semiparametric Bayesian estimation of quantile function for breast cancer survival data with cured fraction.
Gupta C; Cobre J; Polpo A; Sinha D
Biom J; 2016 Sep; 58(5):1164-77. PubMed ID: 27162061
[TBL] [Abstract][Full Text] [Related]
13. Nonparametric estimation of transition probabilities in the non-Markov illness-death model: A comparative study.
de Uña-Álvarez J; Meira-Machado L
Biometrics; 2015 Jun; 71(2):364-75. PubMed ID: 25735883
[TBL] [Abstract][Full Text] [Related]
14. Bayesian model selection: analysis of a survival model with a surviving fraction.
Seltman H; Greenhouse J; Wasserman L
Stat Med; 2001 Jun; 20(11):1681-91. PubMed ID: 11391695
[TBL] [Abstract][Full Text] [Related]
15. Cure fraction model with random effects for regional variation in cancer survival.
Seppä K; Hakulinen T; Kim HJ; Läärä E
Stat Med; 2010 Nov; 29(27):2781-93. PubMed ID: 20862662
[TBL] [Abstract][Full Text] [Related]
16. Estimation for paired binomial data with application to radiation therapy.
Taylor JM; Weiss RE; Li W; Hsu CH; Suwinski R
Stat Med; 2001 Nov; 20(22):3375-90. PubMed ID: 11746324
[TBL] [Abstract][Full Text] [Related]
17. Bayesian cure fraction models with measurement error in the scale mixture of normal distribution.
Marinho ARS; Loschi RH
Stat Methods Med Res; 2020 Sep; 29(9):2411-2444. PubMed ID: 31928318
[TBL] [Abstract][Full Text] [Related]
18. A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data.
Botta L; Goungounga J; Capocaccia R; Romain G; Colonna M; Gatta G; Boussari O; Jooste V
BMC Med Res Methodol; 2023 Mar; 23(1):70. PubMed ID: 36966273
[TBL] [Abstract][Full Text] [Related]
19. Estimating the proportion cured of cancer: some practical advice for users.
Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.
Luo S; Yi M; Huang X; Hunt KK
Stat Med; 2013 Jun; 32(13):2320-34. PubMed ID: 22996169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
